0000905718-17-000825.txt : 20170907
0000905718-17-000825.hdr.sgml : 20170907
20170907170658
ACCESSION NUMBER: 0000905718-17-000825
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170907
FILED AS OF DATE: 20170907
DATE AS OF CHANGE: 20170907
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CONRAD HERBERT J
CENTRAL INDEX KEY: 0001218815
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38022
FILM NUMBER: 171074423
MAIL ADDRESS:
STREET 1: C/O ARBUTUS BIOPHARMA CORP.
STREET 2: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Matinas BioPharma Holdings, Inc.
CENTRAL INDEX KEY: 0001582554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463011414
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1545 ROUTE 206 SOUTH
STREET 2: SUITE 302
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: 908-443-1860
MAIL ADDRESS:
STREET 1: 1545 ROUTE 206 SOUTH
STREET 2: SUITE 302
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
conrad_fm4sept72017.xml
OWNERSHIP DOCUMENT
X0306
4
2017-09-07
0
0001582554
Matinas BioPharma Holdings, Inc.
MTNB
0001218815
CONRAD HERBERT J
C/O MATINAS BIOPHARMA HOLDINGS, INC.
1545 ROUTE 206 SOUTH SUITE 302
BEDMINSTER
NJ
07921
1
0
0
0
Common Stock
2017-09-07
4
P
0
100000
1.30
A
3879600
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.23 to $1.40, inclusive. The reporting person undertakes to provide Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
/s/ Jerome D. Jabbour, attorney-in-fact for Herbert J. Conrad
2017-09-07